Virology Research Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

A novel human pegivirus HPgV-2 (HHpgV-1) is tightly associated with HCV/HIV-1 coinfection

2nd World Conference on STDs, STIs & HIV/AIDS
May 18-19, 2018 | Montreal, Canada

Shixing Tang

Southern Medical University, China

Keynote : Virol Res J

Abstract:

Background: HPgV-2 is a novel blood-borne human pegivirus that mainly infects hepatitis C virus (HCV) and Human Immunodeficiency Virus type one (HIV-1) co-infected subjects. We have investigated the prevalence of HPgV-2 in China, high risk population and its association with HCV and HIV-1. Methods: A cross-sectional study was conducted with both blood donors and HCV and HIV-1 infected patients in Guangzhou, China. All subjects were screened for anti HPgV-2 and HPgV-2 RNA. Demographic and clinical information were obtained from electronic medical records. Results: We tested 8198 serum or plasma samples. Only 0.15% (6/4017) of healthy blood donors was positive for anti HPgV-2, while negative for HPgV-2 RNA. No HPgV-2 viremia was detected in HBV or HIV-1 singly infected individuals. The relatively high frequency of HPgV-2 infection was observed in 1.23% (30/2440) and 0.29% (7/2440) of HCV-infected persons by serological assay and RT-PCR, respectively. Furthermore, anti HPgV-2 and HPgV-2 RNA were detected in 8.91% (18/202) and 3.47% (7/202) of HCV and HIV-1 co-infected subjects. The prevalence of HPgV-2 in HCV and HIV-1 dually-infected people who inject drugs (PWID) was 12.9% in Guangdong and 15.9% in Sichuan. HCV/HIV-1-infected PWID represents a high-risk population for HPgV-2 infection. HPgV-2 persistent infection was documented in about 30% of anti HPgV-2 positive individuals. Conclusion: Our results indicate the rarity of HPgV-2 infection in the general population and tight association with HCV, in particular with HCV and HIV-1 co-infection. HPgV-2 appears not to worsen HCV-related liver damage. Our study provides new findings about the association of HPgV-2 and HCV/HIV1 and the impact of HPgV-2 infection on HCV replication and pathogenesis.

Biography:

Shixing Tang is a Professor at School of Public Health, Southern Medical University, Guangzhou 510515, China.
Email: [email protected]

PDF HTML